SUPERNUS PHARMACEUTICALS, INC. Interest on Convertible Debt, Net of Tax
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Interest on Convertible Debt, Net of Tax of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Notes › Earnings Per Share
us-gaap:InterestOnConvertibleDebtNetOfTax · last filed 2025-02-25
- SUPERNUS PHARMACEUTICALS, INC. interest on convertible debt, net of tax for the quarter ending 2024-06-30 was $0.00.
- SUPERNUS PHARMACEUTICALS, INC. interest on convertible debt, net of tax for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. interest on convertible debt, net of tax for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. interest on convertible debt, net of tax for the quarter ending 2023-09-30 was $0.00.
- SUPERNUS PHARMACEUTICALS, INC. interest on convertible debt, net of tax for fiscal 2024 was $0.00.
- SUPERNUS PHARMACEUTICALS, INC. interest on convertible debt, net of tax for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- SUPERNUS PHARMACEUTICALS, INC. interest on convertible debt, net of tax for fiscal 2022 was $3.56M.
- SUPERNUS PHARMACEUTICALS, INC. interest on convertible debt, net of tax for fiscal 2021 was $0.00.
| Period end | Interest on Convertible Debt, Net of Tax 3 month | Interest on Convertible Debt, Net of Tax 6 month | Interest on Convertible Debt, Net of Tax 9 month | Interest on Convertible Debt, Net of Tax 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-25 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 derived: sum of 4 quarters · filed 2025-02-25 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 10-K · filed 2025-02-25 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-08-06 | $0.00 10-Q · filed 2023-11-08 | $1.78M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-06 | $892.00K 10-Q · filed 2024-08-06 | $1.78M derived: sum of 3 quarters · filed 2025-02-25 | $1.78M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $892.00K 10-Q · filed 2024-05-08 | $1.78M derived: sum of 2 quarters · filed 2025-02-25 | $1.78M derived: sum of 3 quarters · filed 2025-02-25 | $2.67M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $892.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $892.00K derived: sum of 2 quarters · filed 2025-02-25 | $1.78M derived: sum of 3 quarters · filed 2025-02-25 | $3.56M 10-K · filed 2025-02-25 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | $888.00K derived: sum of 2 quarters · filed 2023-11-08 | $2.66M 10-Q · filed 2023-11-08 | $1.77M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $888.00K 10-Q · filed 2023-08-08 | $1.77M 10-Q · filed 2023-08-08 | $1.77M derived: sum of 3 quarters · filed 2023-08-08 | $1.77M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $887.00K 10-Q · filed 2023-05-09 | $887.00K derived: sum of 2 quarters · filed 2023-05-09 | $887.00K derived: sum of 3 quarters · filed 2023-05-09 | $887.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $0.00 derived: sum of 2 quarters · filed 2023-03-09 | $0.00 derived: sum of 3 quarters · filed 2023-03-09 | $0.00 10-K · filed 2023-03-09 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-09 | |||
| 2019-12-31 | $0.00 10-K · filed 2020-02-28 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-02-28 | |||
| 2017-12-31 | $134.00K 10-K · filed 2020-02-28 | |||
| 2017-06-30 | $58.00K 10-Q · filed 2017-08-03 | $147.00K 10-Q · filed 2017-08-03 | $114.00K derived: sum of 3 quarters · filed 2019-03-01 | $316.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $90.00K 10-Q · filed 2017-05-09 | $56.00K derived: sum of 2 quarters · filed 2019-03-01 | $258.00K derived: sum of 3 quarters · filed 2019-03-01 | $454.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $168.00K derived: sum of 2 quarters · filed 2019-03-01 | $364.00K derived: sum of 3 quarters · filed 2019-03-01 | $543.00K 10-K · filed 2019-03-01 |
| 2016-09-30 | $202.00K 10-Q · filed 2017-01-20 | $398.00K derived: sum of 2 quarters · filed 2017-08-03 | $577.00K 10-Q · filed 2017-01-20 | $802.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $196.00K 10-Q · filed 2017-08-03 | $375.00K 10-Q · filed 2017-08-03 | $600.00K derived: sum of 3 quarters · filed 2018-03-01 | $892.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $179.00K 10-Q · filed 2017-05-09 | $404.00K derived: sum of 2 quarters · filed 2018-03-01 | $696.00K derived: sum of 3 quarters · filed 2018-03-01 | $1.03M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $225.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | $517.00K derived: sum of 2 quarters · filed 2018-03-01 | $848.00K derived: sum of 3 quarters · filed 2018-03-01 | $1.23M 10-K · filed 2018-03-01 |
| 2015-09-30 | $292.00K 10-Q/A · filed 2017-01-20 | $623.00K derived: sum of 2 quarters · filed 2017-01-23 | $1.00M 10-Q/A · filed 2017-01-20 | |
| 2015-06-30 | $331.00K 10-Q/A · filed 2017-01-23 | |||
| 2014-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $2.48M derived: sum of 2 quarters · filed 2016-03-09 | $4.96M 10-K · filed 2016-03-09 | |
| 2014-09-30 | $1.29M 10-Q · filed 2015-11-09 | $3.77M 10-Q · filed 2015-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |